FDA Approves Tremfya for Moderate to Severe Plaque Psoriasis … – Managed Care magazine

Posted: July 18, 2017 at 3:44 am


BSA bureau
FDA Approves Tremfya for Moderate to Severe Plaque Psoriasis ...
Managed Care magazine
The FDA has approved guselkumab (Tremfya, Janssen Biotech) for the treatment of adults with moderate to severe plaque psoriasis who are candidates for ...
FDA actions on psoriasis, alopecia top dermatology reads for weekHealio
U.S. FDA approves Janssen's TREMFYA for the treatment of ...BSA bureau (press release)

all 4 news articles »

Go here to see the original:
FDA Approves Tremfya for Moderate to Severe Plaque Psoriasis ... - Managed Care magazine

Related Posts